About LineaGen

LineaGen, Inc. is a content-based biomarker discovery company focused on the commercialization of novel, patentable diagnostic tests that will enable highly effective personalized medicine and healthcare in a variety of key areas. By using individuals' genetic profiles to diagnose health issues and conditions earlier and more accurately, LineaGen diagnostics will support early treatment, greatly improve patients' chances for positive results, and be able to reliably predict those individuals' response to various treatments. One of LineaGen's core competitive advantages is its access to an unmatched biomarker discovery research platform that has been used to help the University of Utah identify more disease-related genes than any other institution in the world. LineaGen is working to develop a diversified portfolio of novel biomarkers for the development of new diagnostic tests, and to strategically license its intellectual property to commercial partners for the development of new therapeutic treatments.

LineaGen current discovery programs focus on key areas, including

• Chronic Obstructive Pulmonary Disease (COPD)
• Autism
• Multiple sclerosis
• Osteoporosis

Our Mission

LineaGen's mission is to work with innovative researchers to create new and valuable discoveries to improve the treatment and management of human health.

LineaGen History and Background

LineaGen grew out of the fertile genetic research environment at the University of Utah. In response to the large number of seminal genetic discoveries being made there... Click here to read more.